Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
Saved in:
| Title: | Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders. |
|---|---|
| Authors: | O'Brien P; IBM Watson Health, 5425 Hollister Avenue, Suite 140, Santa Barbara, CA 93111, USA. Electronic address: marbrien@us.ibm.com., Henke RM; IBM Watson Health, 75 Binney Street, Cambridge, MA 02142, USA. Electronic address: rachel.henke@us.ibm.com., Schaefer MB; IBM Watson Health, 11501 Burnet Road, Austin, TX 78758, USA. Electronic address: mary.beth.schaefer@ibm.com., Lin J; IBM Watson Health, 7700 Old Georgetown Road, Suite 650, Bethesda, MD 20814, USA. Electronic address: janice.r.lin@ibm.com., Creedon TB; Health Equity Research Lab, Cambridge Health Alliance, 1035 Cambridge Street, Cambridge, MA 02141, USA. Electronic address: tbcreedon@challiance.org. |
| Source: | Drug and alcohol dependence [Drug Alcohol Depend] 2020 Dec 01; Vol. 217, pp. 108261. Date of Electronic Publication: 2020 Aug 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Elsevier Country of Publication: Ireland NLM ID: 7513587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0046 (Electronic) Linking ISSN: 03768716 NLM ISO Abbreviation: Drug Alcohol Depend Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
